Sepsis & infection

Peripheral Vasopressor Use in Early Sepsis-Induced Hypotension

JAMA Netw OpenPublished Secondary analysis of the CLOVERS randomised trial

Authors' conclusion

In this prospective cohort study of the CLOVERS trial, peripheral administration of vasopressors was common and was associated with low complication rates.

Study context

Population
Patients in CLOVERS with early sepsis-induced hypotension who received vasopressors within 24 hours of enrollment and had no central venous access at enrollmentof 1563 in CLOVERS
Participants
582 patients
Comparison
Peripheral vs central route of vasopressor initiation
  • Peripheraln = 490
  • Centraln = 92reference
Primary endpoint
Route of vasopressor initiation and associated factors
Methodological detailsprospective cohort, multicentre (60 US hospitals), Data analyzed January 2023 to June 2025; CLOVERS conducted March 2018 to February 2022
  • Prospective cohort
  • Multicentre (60 US hospitals)
  • Data analyzed January 2023 to June 2025; CLOVERS conducted March 2018 to February 2022

Primary result

As reported in the abstract

Factors associated with route of initiation
Study site the only factor independently associated with route of initiation
median OR 3.48 (95% CI 1.57-5.38)

Further findings

OutcomePeripheralCentralaOR (95% CI)
90-day mortality · statistically comparable · adjusted analysis26.1%37.0%0.67 (0.39–1.16)
Peripheral vasopressors continued beyond 6 hours
68.0% · 333 of 490
  • Peripheral vasopressors continued beyond 6 hours: 333 of 490

Safety

Peripheral vasopressor complications · 28 days
0.6% · 3 of 490
Peripheral vasopressor complications — Rare and low-grade; no ulceration or tissue injury
0
  • Peripheral vasopressor complications: 3 of 490

Central venous catheter (CVC) placement complications (CVCs placed in first 72 hours) · 28 days

Complications from CVC placement
14
Patients with complications, of 322 with CVCs
12 (3.7%)

Original publication

Peripheral Vasopressor Use in Early Sepsis-Induced Hypotension. JAMA Netw Open. Published 1 August 2025. doi:10.1001/jamanetworkopen.2025.29148

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.